Clinical Trials Browser

Unknown × Lung Neoplasms × olaparib × Clear all

NCT05245994 2022-02-18

An Open Label, Multicenter Phase 2 Study of Durvalumab (MEDI4736) + Olaparib as Maintenance Therapy in Chinese

Phase 2 Unknown

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01788332 2018-10-26

PIN

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms